Pharma Mar, S.A. (PHMMF)

Other OTC - Other OTC Delayed Price. Currency in USD

68.50

0.00

(0.00%)

As of 02:50PM EST. Market open.

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	68.50
Open	68.88
Bid	0.00 x 0
Ask	0.00 x 0
Day's Range	68.50 - 68.50
52 Week Range	50.85 - 79.38
Volume	8
Avg. Volume	281

Market Cap	1.239B
Beta (5Y Monthly)	0.12
PE Ratio (TTM)	13.54
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	0.65 (0.95%)
Ex-Dividend Date	Jul 13, 2022
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for PHMMF

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

PHARMA MAR SA
Analyst Report: Coloplast A/SColoplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy-care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and wound-care markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
Rating
Fair Value
Economic Moat
4 days agoMorningstar